Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its ...

“We anticipate a highly productive meeting at BIO-Europe Spring as we continue to garner interest in our strategic approach to developing neuroplastogenic molecules, led by EB-003, for the treatment ...

Investor Relations Tiberend Strategic Advisors, Inc. David Irish (231) 632-0002 [email protected] Media Relations Tiberend Strategic Advisors, Inc. Casey McDonald (646) 577-8520 cmcdonald@ ...

“We anticipate a highly productive meeting at BIO-Europe Spring as we continue to garner interest in our strategic approach to developing neuroplastogenic molecules, led by EB-003, for the ...

Celex Oncology is in attendance at the Bio-Europe Spring 2025 scientific congress (17 th - 19 th March) in Milan, Italy, where leadership will be meeting with investors, pharma & biotech companies and ...

today announced its participation in BIO-Europe Spring ®, which is being held in Milan, Italy, March 17-19, 2025.

Peter Rough and Abram Shulsky are senior fellows at Hudson Institute. Europe is suddenly in a hurry. Apparently, the U.S. administration’s overtures to Russia and its suspension of military assistance ...

will present at the 2025 BIO-Europe Spring Convention to be held March 17-19, 2025, in Milan, Italy. The presentation will take place on Tuesday, March 18, 2025, at 9:45 a.m. CET in Coral 1 on Level 2 ...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosimilar market with their robust R&D capabilities and ...

The news moves fast, but understanding takes time. At Vox, we don’t chase every headline. We focus on what really matters. We break down the biggest stories — and the ones others overlook ...